Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Organogenesis Hldgs Q2 Adj. EPS $(0.06) Misses $(0.05) Estimate, Sales $100.78M Miss $101.17M Estimate

Author: Benzinga Newsdesk | August 07, 2025 03:12pm
Organogenesis Hldgs (NASDAQ:ORGO) reported quarterly losses of $(0.06) per share which missed the analyst consensus estimate of $(0.05) by 20 percent. The company reported quarterly sales of $100.78 million which missed the analyst consensus estimate of $101.17 million by 0.38 percent. This is a 22.62 percent decrease over sales of $130.23 million the same period last year.

Posted In: ORGO


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist